New drug tested to tame severe asthma
NCT ID NCT05018299
Summary
This study is testing a new drug called FB704A to see if it is safe and can help control severe asthma. About 20 adults with severe asthma will receive either the drug or a placebo through an IV infusion over 8 weeks. Researchers will measure lung function, asthma symptoms, and quality of life to see if the drug makes a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China Medical University Hospital
RECRUITINGTaichung, Taiwan
Contact
Contact
-
Kaohsiung Chang Gung Memorial Hospital
RECRUITINGKaohsiung City, Taiwan
Contact
Contact
-
NTUH Hsin-Chu Branch
WITHDRAWNHsinchu, Taiwan
-
National Taiwan University Hospital
RECRUITINGTaipei, Taiwan
Contact
Contact
-
Taichung Veterans General Hospital
RECRUITINGTaichung, Taiwan
Contact
Contact
-
Taipei Medical University Hospital
RECRUITINGTaipei, Taiwan
Contact
Contact
-
Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare
RECRUITINGTaipei, Taiwan
Contact
Contact
Contact
-
Taipei Municipal Wanfang Hospital
RECRUITINGTaipei, Taiwan
Contact
Contact
-
Taipei Veterans General Hospital
WITHDRAWNTaipei, Taiwan
Conditions
Explore the condition pages connected to this study.